Home > Healthcare > Medical Devices > Rehabilitation and Assistive Devices > Neurorehabilitation Devices Market

Neurorehabilitation Devices Market Analysis

  • Report ID: GMI7702
  • Published Date: Dec 2023
  • Report Format: PDF

Neurorehabilitation Devices Market Analysis

The neurorehabilitation devices industry by product type is categorized into neurorobotics, wearable devices, brain-computer interface (BCI), non-invasive stimulators, and other product types. The neurorobotics segment garnered USD 604 million revenue size in the year 2023.

 

  • Neurorobotics devices, such as robotic exoskeletons and robotic-assisted therapies, offer personalized and adaptable solutions for individuals with neurological disorders. These devices enable intensive and repetitive training, promoting neuroplasticity and functional recovery.

     

  • Furthermore, the increasing adoption of neurorobotics is projected to propel market growth by addressing the specific rehabilitation needs of patients, enhancing therapy effectiveness, and contributing to improved overall patient outcomes.

     

Thus, the continuous evolution and innovation within the neurorobotics segment further position it as a key catalyst in stimulating the expansion of the neurorehabilitation devices market.

 

Neurorehabilitation Devices Market, By Application (2023)

Based on applications, the market unfolds into distinctive domains such as stroke, multiple sclerosis (MS), Parkinson’s disease, spinal cord injury, traumatic brain injury, cerebral palsy, and other applications. The stroke segment garnered USD 496 million revenue size in the year 2023.

 

  • Its ascendancy is attributed to the high global prevalence of stroke cases and the critical demand for effective rehabilitation solutions. For instance, annually, over 795,000 people in the U.S. suffer a stroke, and about 610,000 of these instances are initial or new strokes, as reported by the Center for Disease Control and Prevention (CDC).

     

  • Moreover, stroke stands as a leading cause of long-term disability, and neurorehabilitation devices play a crucial role in aiding recovery and restoring functional abilities.

     

  • Devices designed for stroke rehabilitation, including robotic exoskeletons, brain-computer interfaces, and virtual reality systems, provide tailored interventions for motor and cognitive impairments.

     

Thus, the growing emphasis on early and intensive rehabilitation for stroke survivors is anticipated to propel market statistics, as these devices contribute to improved patient outcomes and enhanced quality of life.

 

Based on end-use, the market unfolds its segmentation, encompassing the domains of hospitals, specialty clinics, and other end users. The hospitals segment garnered USD 894 million revenue size in the year 2023.

 

  • Hospitals serve as primary centers for acute care, and the integration of neurorehabilitation devices within these facilities ensures comprehensive and specialized rehabilitation services for patients with neurological disorders.

     

  • The availability of advanced medical infrastructure, skilled healthcare professionals, and the capability to handle a diverse range of neurological cases makes hospitals a central hub for neurorehabilitation interventions.

     

  • Additionally, the growing prevalence of neurological disorders, coupled with the increasing awareness of rehabilitation benefits, leads to higher patient admissions to hospitals, thereby accelerating the demand for neurorehabilitation devices.
     
U.S. Neurorehabilitation Devices Market, 2021- 2032 (USD Million)

U.S. neurorehabilitation devices market accounted for USD 693 million revenue size in 2023 and is predicted to witness substantial market growth over the analysis timeline.

 

  • The dominance of the U.S. in the neurorehabilitation devices industry is attributed to the country's advanced healthcare infrastructure, a robust research and development landscape, and a high prevalence of neurological disorders.

     

  • For instance, in 2022, as per estimates, approximately 90,000 adults are diagnosed with Parkinson's disease in the U.S., annually, marking a significant 50% increase from the previous estimate of 60,000 cases per year.

     

  • Thus, as the incidence of neurological disorders rises, there is a growing demand for effective rehabilitation solutions, thereby augmenting market growth in the region.

     

  • Furthermore, the region's proactive approach to adopting emerging technologies, coupled with the presence of key industry players and collaborations between academia and the healthcare sector, continues to propel market growth in the region.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for neurorehabilitation devices was valued at USD 1.9 billion in 2023 and is estimated to reach USD 5.8 billion by 2032 as they are designed to aid in the rehabilitation and recovery of individuals with neurological disorders or injuries.

The neurorobotics segment of neurorehabilitation devices industry garnered USD 604 million in 2023 and will grow significantly through 2032 as these devices enable intensive and repetitive training, promoting neuroplasticity and functional recovery.

The U.S. neurorehabilitation devices market accounted for USD 693 million in 2023 and is predicted to witness substantial growth through 2032 attributed to the country's advanced healthcare infrastructure, a robust R&D landscape, and a high prevalence of neurological disorders.

Bioventus LLC, Ectron Ltd., Hocoma (DIH Medical), BIOMETRICS LTD., Bionik Laboratories Corp., BioXtreme Ltd., Ekso bionics holdings, Inc., Kinestica, Saebo, Inc., Abbott Laboratories, Emotiv Inc., BrainCo, Inc, Permobil AB, and Medtronic Plc.

Neurorehabilitation Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 221
  • Countries covered: 22
  • Pages: 143
 Download Free Sample